Servicing Healthcare Professionals and Companies
Toll Free Phone: 1-866-892-2032
We Accept:
Free Shipping After: $500

Osteoporosis is a significant health concern with far-reaching implications. The gradual weakening of bones increases the risk of fractures, setting off a chain reaction of health complications. Mobility is compromised, independence diminished, and the pain is present practically every day. This disorder particularly poses a threat to aging populations, but luckily, there are more and more osteoporosis medications. We dedicated this category page to innovative therapeutic solutions, so let's find out more together!


Discover More with a Single Click

Our capabilities extend far beyond what is immediately visible. If our current selection doesn't meet your needs, let's delve deeper. Sign up for bespoke consultancy focusing on solutions for your supply challenges.

This bone-weakening disorder primarily results from an imbalance between bone formation and resorption. Factors such as age, hormonal changes, and nutritional deficiencies contribute to decreased bone density. Postmenopausal women are particularly susceptible due to declining estrogen levels, which play a crucial role in maintaining bone strength.

Osteoporosis Treatments

Pharmaceutical solutions become indispensable for cases where lifestyle modifications and nutritional adjustments are not enough. There are two main categories of medications for osteoporosis treatment – anti-resorptive agents and anabolic agents.

Anti-resorptive agents:

Denosumab: A monoclonal antibody, denosumab, targets the RANKL pathway, preventing bone resorption. We will explain it in more detail below.

Bisphosphonates: These medications inhibit bone resorption, preserving bone density. Commonly prescribed bisphosphonates include alendronate, risedronate, and zoledronic acid.

Anabolic Agents:

Teriparatide: This synthetic form of parathyroid hormone stimulates bone formation, promoting the development of solid and healthy bone tissue.

How Does Denosumab Work?

As a monoclonal antibody, denosumab selectively targets the Receptor Activator of the Nuclear Factor-Kappa B Ligand (RANKL) pathway. RANKL is a signaling molecule. It affects the cells that break down bone tissue as part of the natural process.

In simpler terms, denosumab puts the brakes on the cells responsible for bone resorption.

The ultimate goal of denosumab is twofold: to increase bone mass and reduce the risk of fractures. That’s why it’s a fantastic option that’s getting increasingly popular yearly.

If all this intrigues you, our sales agents can help you buy PROLIA®, a trademark of denosumab, at wholesale prices.

Contraindications

While denosumab is an effective therapeutic option, certain conditions must be considered, and, in some cases, alternative approaches are better.

Denosumab, like any drug, has components certain people may be hypersensitive to. The next obstacle is severe kidney impairment. The drug is primarily excreted through the kidneys, and impaired renal function may alter its clearance.

The safety of denosumab during pregnancy and lactation is a critical consideration. Limited data are available on the use of denosumab in pregnant or lactating individuals, and the potential risks to the fetus or infant remain uncertain. Until further studies, we can’t guarantee its safety to this group.

Don’t forget to ask your patient about low blood calcium levels (hypocalcemia). Clients can overcome this, but the intake of calcium and vitamin D must be significantly increased, and this requires additional tests.

There were talks about PROLIA® and vaccines contraindications, especially COVID-19 vaccines, but all that is necessary is to make a gap of about a week between receiving one and the other.

Recovery After Treatment

Quick and easy recovery is what patients especially like about this treatment.

The administration itself causes minimal discomfort during and after the injection. After that, they can expect only a mild reaction in contrast with more invasive treatments.

This does not mean that you should not explain to them how important follow-up appointments are so that you can monitor progress and notice any problems that can arise later.

Bone density assessments and biochemical markers are the primary things you should pay attention to. That way, you will determine both safety and efficiency.

Denosumab Side Effects

Denosumab is generally well-tolerated; clients usually won’t experience any side effects. Still, you have to be aware of side effects and make patients familiar with potential consequences – that is of utmost importance both for the sake of your practice and their satisfaction and safety.

The potential for hypocalcemia is worth mentioning as denosumab inhibits bone resorption. So, there is a theoretical risk of reduced calcium release into the bloodstream.

Another aspect is the reported association between denosumab and an increased risk of infections. While the mechanism behind this is not fully clear, you should monitor for any signs of infections in patients undergoing denosumab therapy.

Skin side effects can manifest as redness, itching, or rash at the injection site. These are mild and short-term problems in 99% of cases.

Osteoporosis Causes

As we have already mentioned, there are many causes. We must first focus on the most frequent causes but not forget the less common ones.

One of the primary contributors to osteoporosis is the relentless march of time. As individuals age, the equilibrium between bone-building osteoblasts and bone-resorbing osteoclasts is disrupted. The result? A gradual decline in bone density makes bones more susceptible to fractures and breaks.

Hormonal changes, particularly in postmenopausal women, play a pivotal role in the onset of osteoporosis. Estrogen, an essential hormone in maintaining bone strength, experiences a significant decline during menopause.

The role of nutrition in bone health cannot be overstated. Inadequate intake of essential nutrients, especially calcium and vitamin D, contributes substantially to decreased bone density.

Genetics also play a role in determining an individual’s predisposition to osteoporosis. A family history of the condition can elevate the risk.

Beyond age and genetics, lifestyle choices significantly impact bone health. Sedentary habits, smoking, excessive alcohol consumption, and a diet lacking in essential nutrients all contribute to the high risk of bone fracture.

Frequently Asked Questions

Does denosumab make you immunosuppressed?

Denosumab does not generally cause immunosuppression. Unlike some medications designed to suppress the immune system, denosumab targets a specific pathway involved in bone regulation and is not known to compromise the overall immune function.

What is a monoclonal antibody?

A monoclonal antibody is a molecule made in a lab that can mimic the immune system’s ability to fight off harmful pathogens, such as viruses or cancer cells. It is designed to bind to specific targets in the body, aiding in diagnosing, treating, or preventing various diseases.

How is denosumab administered?

Denosumab is typically administered in the form of an injection under the skin. This PROLIA® injection technique allows for a controlled release of the medication and is commonly used to treat conditions like osteoporosis by inhibiting bone breakdown.

 

CART (0)

No products in the cart.